SCHEMBL5598085

SCHEMBL5598085

CCCCc1ccc(C#Cc2ccc(CNC3CCCc4ccc(C(=O)O)c(C)c43)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
TAOK1 Q7L7X3 4/20 0.39
TAOK3 Q9H2K8 4/20 0.39
PLK1 P53350 4/20 0.39
PTPN11 Q06124 1/20 0.38
PTPRO Q16827 1/20 0.38
ACACB O00763 1/20 0.37
CTSD P07339 1/20 0.36
BACE1 P56817 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RARB P10826 1/20 0.35
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
S1PR5 Q9H228 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598540 0.87 KDM4E (0.41) KDM4EALDH1A1HDAC1HDAC6
SCHEMBL2857395 0.81 KDM4E (0.48) KDM4ETAOK1TAOK3CTSDBACE1
SCHEMBL2853430 0.76 TAOK1 (0.48) KDM4ETAOK1TAOK3CTSDBACE1
SCHEMBL5598402 0.70 RARB (0.54) PLK1PTPN11PTPRORARBS1PR1
SCHEMBL5598384 0.69 PLK1 (0.54) PLK1PTPN11PTPRORARB
SCHEMBL13711650 0.67 TAOK1 (0.50) KDM4ETAOK1TAOK3CTSDBACE1
SCHEMBL2858924 0.66 RARB (0.61) PLK1ACACBALDH1A1RARBS1PR4
SCHEMBL5598223 0.66 PLK1 (0.50) PLK1PTPN11PTPROALDH1A1RARB
SCHEMBL2851976 0.66 RARB (0.52) PLK1PTPN11PTPROALDH1A1RARB
SCHEMBL1811178 0.65 RARB (0.73) PLK1PTPN11PTPROACACBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS KDM4E 1973/4885TAOK1 3737/4885TAOK3 3756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.